Scientists at Stanford Medicine have identified a naturally occurring molecule that appears to mimic some of the weight loss effects of semaglutide, the drug widely known as Ozempic. In animal studies, the molecule reduced appetite and body weight while avoiding several common side effects such as nausea, constipation, and muscle loss.
The molecule, called BRP, works through a different but related biological pathway and activates distinct groups of neurons in the brain. This suggests it may offer a more precise way to control appetite and metabolism.
